in this issue
Regions :: Western Europe :: Switzerland
Lonza and OncoMed sign process development and manufacturing deal
7:59 AM MDT | October 23, 2012 | Deepti Ramesh
Lonza says it has signed an agreement with OncoMed Pharmaceuticals (Redwood City, CA), a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, for the development and manufacture of OncoMed’s pipeline of anticancer stem-cell therapeutics. Lonza will produce material at its mammalian manufacturing facility at Slough, UK, under the deal. The multiproduct GS system license provides access to Lonza’s GS Gene Expression System and Version 8 Media and Feeds manufacturing platform. OncoMed’s pipeline is focused on the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee